| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |